CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
The "Mohazell" herbal formula in combination with a calorie-restricted diet can improve systemic inflammation in obesity: A randomized double-blind, clinical trial
Authors
H. Akbari
F. Ghalichi
A. Ostadrahimi
E. Valizadeh
Publication date
1 January 2019
Publisher
Abstract
Inflammation is one of the primary mechanisms involved in the development of metabolic complications. The aim of the present study was to determine the effects of "Mohazell", a traditional herbal formula consisting of Origanum vulgare, Carumcarvi, Trachyspermum copticum and Ruta Graveolen in combination with a calorie-restricted diet on biomarkers of systemic inflammation in obese adults. In this double-blind placebo-controlled randomized clinical trial, 68 volunteer obese (Body mass index: 30-35 kg/m2) subjects aged 25-50 years were recruited. Participants were randomly divided into two groups, an intervention group (n=34) and a placebo group (n=34). Each group received either: (1) a low-calorie diet with 3 g/day of 'Mohazell' or (2) a low-calorie diet with 3 g/day placebo for 8 weeks. Patients weight was measured, their BMI was calculated and biochemical parameters such as high Sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-α) and IL-6 were measured at baseline and after the intervention. No side effects were reported with the 'Mohazell' supplementation. 'Mohazell' decreased serum levels of TNF-α (p=0.001) and hs-CRP (p=0.04) in the treatment group. Also, IL-6 decreased insignificantly in both groups (p=0.78). Additionally, significant reductions were observed for weight, BMI, Energy and macronutrients (p<0.05). There were statistically significant differences for weight (0.023), BMI (0.046) and TNF-α (0.001) in between group analysis. The 'Mohazell' supplementation combined with a calorie-restricted diet may modulate systemic inflammatory biomarkers in obese adults. However, more studies are needed to clarify the efficacy of 'Mohazell' as an adjunct therapy to improve inflammatory parameters in obese subjects. © Mattioli 1885
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
kashan university of medical sciences
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.kaums.ac.ir:4763
Last time updated on 31/12/2019